Weight-loss drugs like Ozempic and Wegovy are reshaping healthcare — and potentially the economy.
Dr Zac Turner explains to Sean Aylmer how GLP-1 drugs work, what we’re still learning about their long-term effects, why the next generation matters, and how these medications may go far beyond weight loss.

AI leaders’ dire warnings; ASX wipes out 2026 gains; good news for housing market
17:59

Q+A: The Week Ahead | 14 Sep 2026
09:24

Your super is changing. Here's what to check.
22:16